Skip to main content
Fig. 1 | BMC Infectious Diseases

Fig. 1

From: Sulbactam combined with tigecycline improves outcomes in patients with severe multidrug-resistant Acinetobacter baumannii pneumonia

Fig. 1

MDR-AB inclusion and exclusion flow chart. *Severe immunodeficiency patients: long-term use of immunosuppressants, solid organ transplant patients, recent use of high-dose methylprednisolone drugs (more than 280 mg/w), hematological malignancies, and patients with severe agranulocytosis. MDR-AB, Multi-drug resistant Acinetobacter baumannii

Back to article page